Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Expect a big day tomorrow for VVUS

|Includes: ARNA, OREX, Vivus, Inc. (VVUS)

VVUS rallied in after hour, goes as high as 8.74. The market is expecting some good news tomorrow morning. The efficacy of Qnexa is the best among the three late stage obesity experimental drug, far superior than ARNA and OREX, that will not be any question. The only concern is any major side-effect. If tomorrow the data turned out to be both highly efficacious and relatively safe, that will be a home run, please expect a huge rally of VVUS.
VIVUS to Host Conference Call and Webcast Discussion of Qnexa Phase 3 Results
MOUNTAIN VIEW, Calif., Sept. 8 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, plans to announce the results from the EQUIP and CONQUER Qnexa(NYSE:TM) phase 3 obesity clinical trials on September 9th prior to market open. The announcement will be followed by a webcast and conference call at 8:00 a.m. Eastern time.